RN given refers to (L)-isomer
Also Known As:
N-acetyltyrosine, (D)-isomer; N-acetyltyrosine, (DL)-isomer; acetyl-L-tyrosine
Networked: 17 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results


1. Siu, Tak-Shing: 1 article (01/2013)
2. Lam, Ching-Wan: 1 article (01/2013)
3. Ng, King-Fai: 1 article (01/2013)
4. Tam, Sidney: 1 article (01/2013)
5. Mak, Chloe Miu: 1 article (01/2013)
6. Chim, Stella: 1 article (01/2013)
7. Korman, Stanley H: 1 article (07/2004)
8. Gutman, Alisa: 1 article (07/2004)

Related Diseases

1. Tetanus
2. Hypersensitivity (Allergy)
01/01/1981 - "However it was shown that all the compounds had slight or no adjuvant activity on the induction of delayed-type hypersensitivity to ABA-N-acetyl-L-tyrosine. "
04/01/1979 - "Synthetic 6-O-mycoloyl-N-acetylmuramyl-L-seryl-D-isoglutamine was active as an adjuvant for the induction of delayed-type hypersensitivity to m-[4-(4'-arsono-phenylazo)-phenyl]-N-acetyl-L-tyrosine in guinea pigs and for cell-mediated cytotoxicity in allogeneic mice. "
08/01/1988 - "All the multiprenylacetyl MDP derivatives, particularly TMD-232, showed potent adjuvant activity on the circulating antibody formation against bacterial alpha-amylase in mice, and induction of delayed-type hypersensitivity to monoazobenzenearsonate N-acetyl-L-tyrosine in guinea-pigs. "
01/01/1981 - "N-Acetyl muramyl-L-valyl-D-isoglutamine (MurNac-L-Val-D-isoGln), QS-10-MurNAc-L-Val-D-isoGln, and their methyl esters were shown to have potent adjuvant activity on the induction of delayed-type hypersensitivity to monoazobenzenarsonate-N-acetyl-L-tyrosine in guinea pigs and on the primary immune response against sheep erythrocytes in vitro; however, only QS-10-MurNAc-L-Val-D-isoGln methyl ester, i.e., QS-10-MurNAc-L-Val-D-Glu(OCH3)NH2 (quinonyl-MDP-66), was shown to be an active adjuvant for the induction of allogeneic killer T cells in mice and the suppression of tumor growth in syngeneic mice when it was administered as a suspension in phosphate-buffered saline. "
07/01/1976 - "It was concluded that the minimal adjuvant-active subunit of cell wall peptidoglycan for the induction of delayed-type hypersensitivity to monoazobenzenearsonate-N-acetyl-L-tyrosine and for circulating-antibody formation to bacterial alpha-amylase and the thymus-independent antigen DNP-Ficoll was N-acetylmuramyldipeptide, MurNAc-L-Ala-D-isoGln. "
3. Tyrosinemias (Tyrosinemia)
4. Delayed Hypersensitivity (Hypersensitivity, Type IV)
5. Liver Failure

Related Drugs and Biologics

1. Immunoglobulin M (IgM)
2. Immunoglobulin G (IgG)
3. Antigen-Antibody Complex (Immune Complex)
4. Tyrosine (L-Tyrosine)
5. glycyltyrosine (Gly-Tyr)
6. Phenylalanine (L-Phenylalanine)
7. Dipeptides
8. alpha-Amylases
9. arsonic acid
10. alanyltyrosine

Related Therapies and Procedures

1. Total Parenteral Nutrition
2. Parenteral Nutrition
3. Renal Dialysis (Hemodialysis)